Audio Medica - Medical Audio News Interviews & Podcasts

Malaria—Insecticide Research Promises To Beat Mosquito Resistance

Malaria Elimination: Research Findings At ASTMH Conference

November 12, 2011

Lab In A Box Fights Malaria In The Villages

November 12, 2011

Ready-To-Use Food Supplement Could Help Treat Sickle Cell Disease

November 12, 2011

Non-Malaria Fever Danger To Children

Bendamustine trumps chlorambucil for unfit patients with chronic lymphocytic leukaemia?

Wolfgang Knauf

LONDON— A change of therapy from chlorambucil to bendamustine was being recommended at the European Haematology Association annual meeting (June 8-12, 2011) for patients with chronic lymphocytic leukemia who are not fit enough to receive the gold-standard FCR chemo-immunotherapy. In a debate with Professor Peter Hillmen from Leeds University in England Wolfgang Knauf, Professor of Haematology from Frankfurt, Germany, opposed the motion that “chlorambucil is still the chemotherapy of choice” for this patient group.

More news from the EHA congress at http://www.ecancermedicalscience.com.

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

More from Oncology:

June 15, 2011

Myelofibrosis: dramatic responses to JAK II R inhibitor ruxolitinib

April 17, 2011

Best supportive care: no longer the obvious choice for elderly patients with acute myeloid leukaemia

April 16, 2011

Chronic lymphocytic leukaemia: studies give insights into treatment beyond chlorambucil for elderly patients

April 16, 2011

Evidence biased medicine should not be used for clinical decision-making in geriatric oncology

April 14, 2011

Quiet rationing of cancer drugs discriminates against elderly patients

Click Here for All Oncology Interviews

Global Health

January 22, 2012

Safety of Antimalarial Drugs in Africa — Vigilance Needed

David Schellenberg

PHILADELPHIA—Pharmaco-vigilance was being urged here — as a key part of the strategy to improve malaria control in Africa and elsewhere — in a special session devoted to malaria drug safety at the American Society of Tropical Medicine and Hygiene annual conference. With the battle against malaria slowly being won in Africa, the safety of anti-malarial drugs is of paramount importance now they are being used more widely than ever. Session chair Professor David Schellenberg of the London School of Hygiene and Tropical Medicine told Peter Goodwin about their findings and conclusions.

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.